the eua for five to 11-year-olds could happen before halloween. doctors agree with that timeline. while there are several steps that need to happen before that decision, counties across the bay area tell us they are preparing now so vaccination clinics for kids can open immediately after. protecting the unprotected. that is the hope pfizer's covid vaccine is giving anxious parents with young children a cost -- across the bay area. >> can little sad. reporter: their gory ramirez lives in san francisco's mission district. he works as a delivery truck driver and worries he is putting his five-year-old son at risk. >> i go to my work, every day, different people. some people don't like to vaccinate. reporter: and he is not alone. >> have families that are completely -- the whole family unit is sick from the baby, two months old, to the oldest person. reporter: susanna rojas is with the san francisco's covid-19 latino task force. her staff is preparing to expand the mission's 24th and cap street pop-up sites, to vaccinate up to 500 children per day, once pfizer's vaccine is authorized.

moderna applied for that vaccine back in june but the fda has still not granted them full eua for thatapproved for adults over the age of 18. what we're lacking at in terms of the younger age group social security that we're hoping to get data from the five to 12-year-old age group. and then it will not be october to november before shots go into arms for that younger group for pfizer. we're hoping to get data on the younger than five-year-olds and for moderna we're hoping to get the eua for the 6 to 12-year-olds at the end of the year and younger than that early quarter 2022. the issue of these authorizations and approvals for advantage seens is just a very, very different process than it is for adults. it is taking a longer time to consent. some kids are needlephobic. why is that? with children we have to be even more certain that we're offering is truly safe and effective. and we have toy think about dosing as well. not only deescalating doses, but also going down, you know, in a stepped down fashion for all of those age groups. >> yeah, when we talk about the delta variant and the

we know that prior application for the eua for adolescents bass processed after about a month by thet's going to be a few weeks after the company submits the eua before the shots are available for kids. so my guess is that we are going to be into november before we see this for children. >> when this vaccine is authorized it would make 28 million children eligible, but there is an axios inowes poll that says 42% say they won't vaccinate their children. 28 million children. how critical to get their parents onboard? >> well, there is no other way for the kids to get vaccinated. presumably, some school boards will start to mandate vaccines for kids, and that might help. but mind you, if you look at the experience for what's happened when the vaccine was approved for adolescents, barely half of the kids eligible in the 12 to 15 year age group have been vaccinated. so we have a long way to go to educate parents about why this vaccine is important for their children. and it's going to be split again among party lines, split among parents who have been vaccinated and unvaccinated, with the

so they're going to get enough data for an eua probably mid, end of october. so within the next several weeks, a month, month and a half we should have enough data to make determination is it safe and effective to give it to children 11 years of age and younger? >> dr. fauci more than 100,000 people are hospitalized because of covid right now. some hospitals are overwhelmed, starting to ration care. now people have a choice to prevent covid illness or serious illness or death and aren't taking it, how should doctors choose if it comes to that who receives an icu bed? and should, you know, field hospitals reopen in certain parts of the country? >> anderson, if you're asking should you preference it for a vaccinated person versus an unvaccinated person, that's something that is always widely discussed. but in medicine i know that you don't prejudice against someone because of their behavior. just don't do that in medicine. there'd have to be some other medically sound reason on the evaluation of one person versus another whether you're going to give scarce resou

we have a lot of big moves on the horizon, hopefully eua for kids under 12, the rollout of mandates that might get more unvaccinated people vaccinated. what are you hopeful for sm what does it spell for the upcoming winter? >> certainly, this virus has been humbling. so, i want to remember all of those twists and turns i've had over the last literally 18 months and why this may be a really bright step out of it and i think that we have some really bright steps. i can see a future where we have the majority of the public vaccinated and we're working to vaccinate other people around the world and that we are optimizing boosters, vaccine effectiveness with boosters in the united states where children are started to get vaccinated and feeling comfortable being back at school. and i absolutely can see those times and what really gives me hope and there's been so many challenges with this. and so much dissension around it, but the things that i find beautiful are where people have really come together in the spirit of helping one another and those stories are fewer and far between. i don't thi

i think it's about a month probably until pfizer grants the eua and i think this is the right timing, as she said. we're going into cold and flu season. we are already seeing increased cases of rsv, other illses putting kids in the hospital. flu is starting on the east coast now and going to make its way across the country, and don't forget, it's time to get the flu vaccines right now, but we all need to work together to keep our kids healthy and safe and in school. once we begin vaccinating these kids, then we can take a look at all of the other mitigation strategies that we're using in schools, such as the masking and the distancing and the ventilation, and once numbers are at a low level, we can start peeling back some of those and get back to normalcy, which is what we need. it's been i think too long and our kids are waiting for this. >> yes, they need their lives back for sure, and this may be the key to doing that safely, dr. wen. can you talk to us a little bit about the dosing here? because this and i think parents need to know this. this is not the adult shot. ten micrograms

in november the eua, it's likely to be fully approved. you look at the fda, they don't approve things unless they're safe. >> i want to look at the data here. how many teenagers have gotten at least one dose? 71% of 16 and 17-year-olds got one dose, 12 to it 15-year-olds, 67% got at least one dose. will others follow suit? >> it's how you're communicating it, which i can hear it in your voice. it's not to force anyone, it's to say this is the best way to get back to normal. that's positive messaging. that's exactly what you want. so i absolutely think there is no doubt mandates have always increased uptick. we've mandated vaccines since 1900 in this country. so it's nothing new, and it is the right approach to get them up higher. >> sam, if you could just help us clarify here. what are you thinking? can you circle a date on the calendar when you're going to impose these rules? does it come january after winter break when they want everyone vaccinated? >> well, we asked the superintendent to bring a plan back to us. we're asking her to als

then it's up to the fda to decide when they're going to issue that amendment to the eua. that depends on how long it takes for them to look at the data. if you look at it conservatively and a destination date, i think most people think by halloween we should have vaccinations for kids 5-11. >> thank you for your time and insight this evening. >> thanks so much, raj. >>> up next, the ugly side of social media. a report suggests that instagram can be toxic, especially for teenaged girls. is facebook, the parent company here, doing enough to protect the teenager? >>> and a former theranos employee called in to testify in the trial of elizabeth holmes in san jose. what that employee says she experienced during her time at theranos. >>> and this spaceflight making history a couple hours ago. (music) ♪ i think to myself ♪ ♪ what a wonderful world ♪ attention, california. new federal funding of $3 billion is available to help more people pay for health insurance — no matter what your income. how much is yours? julie and bob are paying $700 less, every month. dee got comprehensiv

tom: pfizer, formal eua submission in coming weeks and on and on. with children, one in five cases deemed to be children. what happens to this nation when we finally get five to 12-year-olds vaccinated? >> i think what you will see is the virus will have a hard time infecting children. what it also will do is allow children to get their lives back because we know their lives have been on hold, even though they tend to be spared from severe disease. it can be difficult to have these activities without covid-19. having five to 11-year-olds being vaccinated allows them to have a normal childhood and protects them against destruction from covid-19 and allows schools to be having policies. tom: it dovetails into your observation on what the governor is having to deal with today. jonathan: just how bad are things in new york city and elsewhere. what kind of shortages could we face? dr. adalja: the anti-back health care workers, especially nurses. you will see hospitals worried about how they will continue. in the long run is better to get these people out

it is what is under eua right now.ust 23rd when they approve the pfizer vaccine for adults, they still kept it under what is called emergency use authorization for 12 to 15 years olds to follow out the participants in the 12 to 15-year-old trial and make sure safety is intact. so they likely will approve it probably in november, and that's when vaccine mandates would come, but the reason they're doing it is, again, they are following children out for safety. the myocarditis issue is being fold. they're looking at the safety a lot between 12 and 15 now. >> let's look at how many covid cases reported in our school. since the beginning of this school year oakland has had 306 students test positive for covid and they've put 19 classes in temporary quarantine. west contra costa school district reported 166 student cases and 19 classrooms had to be temporarily closed. dr. gandhi, let's put this in perspective. is this a lot of cases or is it par for the course here based on the numbers? >> these are more cases than we've see

i don't think that would slow it down >> fda approval or eua >> fda of an eua it takes them four-to-sixo you that. my guess is they would go through the do you that immediately. not await the request from pfizer, which is a few weeks out. if that's the case, we would be on track for kids to be vaccinated by halloween, potentially. that's five weeks. >> i'm ready to hyperdrive my anti-bodies. >> the third shot? >> right off the charts. lay it on me you know, i feel it pretty at the strong already famous last words. but, what? you know i have a good immune system, right? >> you have a very good immune system >> you do. >> you set the bar this is a pivotal week on capitol hill for president biden's agenda on infrastructure and the implications from the markets. let's welcome aei good fellow jimmy petakukas, a cnbc contributor. thank you for joining us i was talking about me, how about grassley, 88 years old, running again for a six-year term he tweeted it out at 4:15 a.m. getting ready for a 5-mile run do we need someone to follow in the footsteps? william shatner? >> william shatner, unbe

by the way, the trial, about 2300 kids ages 5 to 11, safe and robust response, they'll smith for an eua as soon as possible here is what board member scott gottlieb said on squawk this morning? >> pfizer is in a position to file quickly the data came earlier than some were expecting deng on how long the rue vie takes, you can't have a vaccine available to children as early probably by the end of october, perhaps it slips a bit into november >> it's two doses, the same vaccine, but a smaller dose, three weeks apart. they did add they did see fewer side effects than, for example teens have gotten, sore arms, that kind of things. >> this is one of the things we get excited about it. >> people in the northeast i think will go for it, and then, david, people in the south -- remember we have a sizable people who just don't think this works -- well, they have a million reasons not to give it to kids. can we accept the fact that we now have a situation in this country where basically half the country thinking -- >> it's not hat. >> the numbers would indicate 25%. but that's an enormous amount o

this age group, but to make that determination, hallie, will require that pfizer files for a formal euathe fda, who will then review it over the next number of weeks and their advisory committee will meet, likely in a public hearing, to deliberate and review rigorously the data and make a recommendation for the fda, and then it gets to the cdc who will make a recommendation on who exactly should get the vaccine. >> thank you both. we'll talk about this later in the show, but we want to get to those developments from wall street. dom chu is here with us. let me take a look, because the dow is down nearly 900 points. we hear it a lot, the markets are not the economy, the economy is not the markets, but for people with 401(k)s and stocks, they're wondering what happened today? >> we haven't had a pullback since february of this year. we haven't seen a significant pullback since october last year. this is unusual -- you mentioned the dow dropped about 900 points. we were down about 940 some-odd points, pushing toward the down 1,000 mark. mentioned the covid segment. those worries still pers

then it took about another month on may 10th for that eua to be amended to include that age group. ana, this couldn't come at a more critical time. we know kids are going back to school, parents are deeply concerned. there are schools not allowing masks. there's also playing into what exactly is going on with the economy. adults aren't sure if they can go back to work. are they going to need to keep their kids at home and for those parents out here learning what went into a study, i want to show you one quick thing here participant-wise. more than 2,000 participants, all 5 to 11-year-olds, it's a two-dose regimen like adults and robust antibodies produces. >> let's bring in our own doctor from emery school university of medicine. dr. shane, this is big news and we just heard from dr. scott gotlieb saying this could be rolled out for kids 5 to 11 by the end of okay. how much could this change the current situation in the u.s.? >> thanks, ana. great question and we are as pediatricians and everyone is very excited about this news and the ability to vaccinate 5 to 11-year-olds in addi

but please remember that those medications also have an emergency use authorization so don't let the eua for the covid vaccine be the reason that you're not getting it. know that these other medications are just as new and just as potentially dangerous and aggressive is and so we would rather keep you out of the hospital with the vaccine very much in the same way. that's such an important point? >> a lot of these alternative therapies people are seeking out are having the same approvals. what's the hesitation with just getting the vaccine, right? >> right. >> thank you for your time. we appreciate you sharing your story. thank you so much. >> so i want to tell you about what's happening in southern california right now. a 4.3 magnitude earthquake struck the area. this was according to the usgs. it was felt throughout los angeles and that area and surrounding cities. some people reported feeling a jolt that ranged from a moment to as much as 10 seconds. so far no immediate injuries or significant damage have been reported thankfully but the los angeles fire department says they are in ear

will the drug companies submit by the early fall, will eua be submitted by october?rents need answers. >> daily covid cases now the highest since january, something more than 99% of the people going to the hospital, they have not had the vaccine. this is still a crisis of the unvaccinated. from your perspective, what is the breaking point here from hospitals? i hear hospital systems saying that they are putting off elective procedures so that they can have room, space for these unvaccinated people coming into their ers. what is the breaking point? >> i'm going to say that the breaking point actually are the staff. we talk about this day in and day out. the emotional well-being of our staff, those staff will be leaguered, those staff are traumatized. we're in a pandemic that appears to never let up. but the public can help with that, the public can help by being vaccinated. so your likelihood of being hospitalized will drop significantly. the public can help with that by wearing masks in indoor spaces and the states and federal government has to understand the importa

i do expect them to come out with an eua that follows the advisory. >>> the cdc met day to start debating for for a booster shot. who do you hope is included? >> the data from israel suggests that people over 60. the fda had initially thought over 65, but somewhere in that range, people who are melly high risk, people with chronic diseases, and then also people who are at high risk because of their profession -- physicians, nurses, i think those are the groups i will be looking for. >> i suspect you're right. cdc data, by the way, shows that the pace of vaccinations is the slowest in two months. how concerning is this? right now we're losing about 2,000 americans every single day. it's the highest it's been in six months, more than 2,000 americans dying every day. >> yeah, first of all, those numbers are just heartbreaking. of course, almost all preventable, because we have a vaccine-preventable disease. i am worried about the slowing of the vaccination. i think what happened is there was a big surge in the south, and that has cooled. i hope as the mandates go into effect, we'll see more.

. >> the therapeutics, these pills could be -- you could have an eua before the end of the year, almostbefore december 20th, winter. >> yeah. with the trials that are underway looking at reduction in symptoms and prevention of progression of severe disease, those are the first trials that got underway you could have a readout from pfizer, roche and merck before the end of the year that could lead to an eua the trial is looking at prevention of infection and close contacts got started later, so they're going to read out later. >> but that's a game changer remdesivir, the whole process is almost like a catch 22. >> yeah, it has to be infused. >> and you have to do it early >> we have the monoclonal antibodies, they are highly effective. they are available right now and can be used as a prophylaxis they need to be infeesed but they're working on drugs that could be administered in a doctor's office. i don't think people don't reach for them, because they seem to be complicated, but they're really not. >> we need all these arrows in the quiver once again, the book "uncontrolled spread." >>>

i have confidence that if they feel that they are going to present that to the fda for an eua approval, i doubt very seriously that there's anything to be concerned about in that data. >> why is it that a 12-year-old child is getting vaccinated with a full dose that is three times the size of the dose that will be given to an 11-year-old? is the distinction based on development, weight, something else because there's a lot of confusion out there for a lot of parents who have children in that specific age range? >> that's understandable, wolf, but you've got to have a cutoff point and do something that's logistically feasible. if you start talking about multiple different doses down by weight, for example, a microgram per kilogram regimen, that's going to be confusing. it's going to be more confusing than what you're talking about right now, so you have to have a cutoff point. the decision was children from 11 down instead of getting the 30 microgram dose will get a 10 microgram dose. i don't think there's anything wrong with that and parents should not be confused or concerned about th

i think health care professionals were part of the eua, as well, because the concern is if you get a lot of health care professionals sick, even if it's mild illness when hospitals are overwhelmed, that's a problem. so i think they may be included in the first group, as well. >> dr. jha, why do you think the biden administration did what they did? eight months after the second shot, get a booster shot? he saiding advised by his medical experts. he didn't go out on a limb because he felt like it. there is a lot of fighting going on between the fda, the cdc, the white house. how concerning is that to you? >> yeah, so what is interesting about this is when president biden came out with that, you know, he had both dr. woodcock and dr. walensky, part of that decision making. there was a little puzzling why there is a bit of a disconnect. the advisory committee is an independent outside advisory committee. it possible the fda could still rule that they're going to authorize vaccines or boosters for everybody. that's still on the table. because they don't have to listen to their advisory co

i hope the fda can approve, give eua for vaccines for children 5 to 11. put again, what's important is getting cases overall down, getting as many people vaccinated as possible. >> the issue of the third shot or booster, dr. hotez, the messaging on this has been to use the word mixed is probably being gentle, it has been confusing. my mother doesn't know when she's supposed to get a booster. what is the definition of immuno compromised, anybody over a certain age or if you have this, this, and this. i assume you're hoping that gets cleared up a little today. >> yeah. as we talked in the past, chuck, i thought the two mrna vaccines were a three dose vaccine and the j&j were two dose vaccine. part of the problem wasn't messaged from the very beginning. and so now we're playing catchup on that. and to add to the confusion, we don't have a lot of data in front of us to know the extent to which immunity is declining. >> why is that, why do we have this data issue. >> all the data is coming out of israel and the uk. that's why we have no information on moderna

that was the first that got eua authorization, obviously, emergency use.omeone gets a pfizer shot, and that's more preif elect in the united states than moderna, does that mean they get a pfizer shot, and if they get it, you have to wait for a moderna shot in there were reports last week they were going to give you pfizer whether you had moderna or pfizer. can you clarify the confusion in all of this? >> sure. so the pfizer vaccine has just been approved. now, there have been many studies where people have tried mixing and matching partially because some countries just don't have receive enough, and those studies tend to suggest it's safe and sometimes beneficial. they aren't run the studies where they mixed and matched the vaccines like they have with the dedicated agents, but because it appears safe, it is possible that companies would come up with strategies as a function of the availability of the vaccine in terms of which booster you get next and that, little, is going to be decided by local governments. cheryl: i also want to ask you about children.

previa showed it was effective and safe, they submitted data, but they're not officially asking for the eua. what do we make of it? >> yeah. >> that we're on our way. and that this will happen, but that it hasn't quite happened yet. so as you said, pfizer says that over the next couple of weeks and the next few weeks that they expect to be applying for emergency use authorization, from the u.s. food and drug administration, but they haven't done that yet, all they have done is submit data and we don't even know what that data is. so let's talk about what we do know and what we don't know. here's what we do know, pfizer last week put out a press release saying that they did a clinical trial with more than 2200 participants, those children ages 5 to 11 were given one-third the dose given to adults and the vaccine was safe and that the children had a robust antibody response. according to pfizer. here's what we don't know, the thing we want to know here is had th when children got the vaccine, were they less likely to contract covid and get sick from it compared to children who were given a pl

when we looked at previous data submissions and the time course of how it took to get to eua, maybe as are sometime late september, early october, sometime in the fall. >> parents are getting anxious to say the least. >> i know. >> sanjay, we're learning how many people in the u.s. are estimated to have antibodies to covid-19. that includes i imagine vaccines and people who have been infected before. so what does this say about the chances of reaching, if it's still possible, herd immunity? >> well, let me show you this graph because i find this really interesting. there was a study, i'll tell you, as you're look at this graph, back in may of this year saying 150 million people, maybe less, have been exposed to the virus, 150 million. now we're saying there's around 20% that have detectable anti-bodies. one time it was closer to 45% and now it's 20% which gives you some idea that natural immunity, which is the line sort of at the bottom there is very significant, but those antibodies do seem to wane. we're about 80% of people in the country right now have antibodies. the majority, aga

it's really tough for a public school in particular to put a mandate in place under an eua or emergencyanticipate that within a year or so, covid-19 vaccines wil will join the large list of vaccines we already demand for our kids before they go to kindergarten and throughout their school career. a way to not just keep them but everyone else in the school safe. >> throughout this pandemic, we've seen a number of politicians who talk about the need for masking, for vaccination, et cetera, caught doing otherwise, whether it's the mayor of washington, d.c., whether it's other politicians. we just saw over the weekend new footage of san francisco mayor london breed being filmed, caught on video at a nightclub without a mask on. obviously local public health guidance in san francisco requires everyone to wear a mask indoors at all times, including those who are vaccinated. unless they are actively eating or drinking, neither of which she's doing in the video. she is standing and dancing. listen to mayor breed's defense. >> i was there. i was eating. and i was drinking. and i was sitting with

and if it is they'll seriously consider an eua.hat's an if, i don't want to second guess them, then you could probably have approval for at least one of the products as you get into october. >> what do you think, could we see a vaccine for young kids by october? >> we could, but here's the thing. you know, i'm a pediatrician in my background. i am certainly concerned we want to get the emergency use authorization as quickly as possible but we don't want to skip over parts of the process that will assure us that the -- that the vaccine is safe. and by the way, children, you know, are not little adults. the doses will vary according to the weight. and age of the child, and this is something that has to be processed by the fda. what is the right dose for a 5-year-old, a 7-year-old? we don't quite know yet and that's the information that we have to understand before we issue an emergency use authorization but i totally agree with dr. fauci, we could see the vaccine for kids next month but certainly by the end of the year, lindsey. >> g

>> if the eua application goes in this week, i would say it will go to committee probably sometime byto go through two committees. it has to go through the fda's vrbac committee and it will have to go over to asip over in cdc. there's a lot to talk about. this is a vaccine for children, so getting the dose right in terms of both efficacy and side effects is crucial. and this is not the same dose of the pfizer vaccine that i got. this is a reduced dose vaccine, so there's a lot of data for the fda and cdc to look at. >> and what do we do to help parents overcome reluctance to get their kids this vaccine because now we're talking about younger children. >> yeah. >> so parents of course will be concerned about that. obviously we're going to get into a conversation about whether mandates are appropriate and so on. i can't imagine that we would get to that point, but what are your thoughts? >> well, look, parents are accustomed to vaccinating their kids. no parent in any state in the u.s. can send their child to school without giving them almost a dozen vaccines. so parents are very accust

the data show it's safe, but this is again, even if it gets approval, it's going to be an eua at first. and generally, we are talking about the lowest risk group. we are talking about children. so where do you fall on this, dr. gottlieb? do you think it should be mandated for children as soon as it's approved? or not? >> look, vaccination among kids who are eligible right now is about 50%. so we're not seeing the uptick among kids. i think pediatricians are going to have to work hard with families to try to encourage them to get children vaccinated. we're not going to see childhood vaccinations mandated until these vaccines are fully approved, and there's multiple vaccines on the market. it might not happen until fall 2021-2022 school season. cdc is going to have to take a recommendation to put this in a child immunization schedule. some states have to pass separate laws to enable that. i think eventually it ends up there, but i think this is a longer-term plan. i think the thing we can do most immediately in terms of trying to get more people vaccinated who are at high risk is require

making the statement that because this is a public vaccine and provided by the government and under euasaying it shouldn't be used outside of the recommendations they are making now. the c.d.c. director still has to accept the recommendations and sign off she essentially always does. we will see if she does here for now, it should be more narrowly recommended to use. we know people are already going to the pharmacies and getting things >> meg, really, really interesting. thanks so much looking ahead to tomorrow, carnival gearing up to report earnings >> reporter: hey, carnival now aiming to get more than half of the fleet sailing by october, earlier than investors anticipated but well behind royal caribbean which has been more aggressive in the restart with 70% of the ships at sea the question is how the past summer of not so smooth sailing and confusion has impacted bookings for the winter season shares of carnival are down about 1% from the recent high. >>> thank you. don't miss our exclusive interview with the carnival ceo arnold donald tomorrow 4:00 eastern time obviously always loo

according to the study they presented yesterday, it's active against variants, and an eua, smith saidstill possible by the year end. >> i think we have some sound from him the new ceo of merck, we'll do the faber report as well, and talk about the exceleron deal. it was 180 price, and merck is buying it's interesting the deal itself as you watch those shares retreat ago bit. there had been some anticipation it would be even above $180. we're talking about $11.5 billion. this is the key drug here. the other drug you're looking at, the royalties, it was a celgene partnership from years back so totercep is the keep drug here, and it came back celgene didn't want to develop it at that point, and they have. and it was in early 2020 when he got phase two data from that you can see that the stock did move up at that point pretty dramatically. but we're still waiting on phase three, which is an important component here this is the largest price ever paid for a company without what we would call pivotal phase three data, the $11.5 billion. merck is taking a big risk the face three data, they'r

under eua, companies that have that authorization cannot talk directly to health care providers. rep. griffith: what are they prohibited receiving information about vaccines that do not have the fda-approved labeling in addition to health care providers that you mentioned? ms. arthur: companies focus their direct energies on information to health care providers, pharmacist, nurses, and doctors. that is the primary audience they would share information with. those providers would share information with the general public. companies also do talk to insurance companies and state health departments as well. rep. griffith: covid has gotten a lot of attention. how might they use information about vaccines? if we see a problem in the future, maybe not the whole country, do you think it would be helpful if companies were able to share that information with health care providers? ms. arthur: i do. i think it is important because companies should have a way to, with the approval of the fda, following the guidelines of their authorization, to be able to speak to health providers so that the

if it is, they will seriously consider an eua. that being the case, if they do that and that's an if. i don't want to second guess them then you can have approval for one of the products as you get into october. you can't get ahead of the fda. that's a possibility. >> okay. the cdc releasing some data tomorrow which they previewed today. the weekly covid-19 associated hospitalization rate per 100,000 children was nearly five times the rate in the weekendsing june 26th of children 0 to 4 years. is this the case this is more dangerous for kids than previous variants and is that what the data is saying? >> it doesn't necessarily say that, chris. what it says, we know delta is a bad actor. it transmits extremely efficiently so you are seeing more people, every one, adults and children getting infected. the more children getting infected, a certain proportion of them will require hospitalization. the more children get infected, the more kids you'll see that are going to require hospitalization. we do not know yet, we don't have enough

and if it is, they will seriously consider an eua.t being the case, if they do that, and that's an if, i don't want to second-guess them, then you could probably have approval for at least one of the products as you get into october. but, again, you can't get ahead of the fda, but that's at least a possibility. >> okay. that's a useful -- the cdc releasing some data, i think, tomorrow which they previewed today on children and delta. i want to read from part of it. the weekly hospitalization rate per 100,000 children during the week ending august 14th was nearly five times. rate during the week ending june 26th among children aged 0 to 4 years. the weekly hospitalization rate ending august 14 was ten times that during the week ending june 26. there is a question here of is it the case that this is more dangerous for kids than previous variants and is that what the data is saying? >> it doesn't necessarily say that, chris. what it says, we know delta is a bad actor. it transmits extremely efficiently. so you are seeing more people, eve

those should be filed with the agency very shortly and at that point the formal eua request will be made data remember this pediatric dose is a lower dose of the existing formulation. so they have all the experience with the existing formulation of the vaccine. so i think they will be able to move more efficiently. i would say the end of october and i've long said end of october is a possibility it's an optimistic possibility if it slipped, it can slip from mid-november you also have to put against this bookdrop the fact that there has been a lot of turnover in that division inside the fda to senior leaders leading that division so that will put added strain on them typically, there aren't a lot of vaccines approved. that's a small group to begin with it's been under tremendous strain i still think the end of october is possible. if it slips, it could slip from mid-november which is where i have been all along. >> can i ask you a different question, which is of a hesitancy, in this case, that parents may have to provide the vaccine for their children there is a lot of parents out there,

final approval for the booster shots to proceed at a vote for this afternoon, like we saw the original eua was enough for a lot of people. i think we need to do moderna, have the people got moderna instead of pfizer -- >> that's going to be in a couple weeks >> you may not need them as much at the moment. >> moderna is not done with the data i think that will be cleared in the near futuretoo. >> it appears to be a little bit more durable, so maybe get a couple months extra out of it, we'll see. the part about the booster shot that moderna is creating is actually a different amount in the booster. so right now the pfizer booster is the -- >> the same as the second hot. >> that's right. the moderna booster is going to be some fraction of what the -- >> a little bit less, yeah. >> -- of what the other one was. >> that leads to not only does the data have to come before the fda and clear it, then you would need to get different shots out to -- distributed to all of these places >> doing it the way moderna is doing it will make it more complicated. it may be the way to do it but it does. >>> co

the fda met earlier and they recommended that it be given to a certain population, then their eua wept recommended then the cdc met their advisory committee met yesterday, and they were more restrictive in what they recommended. they didn't include healthcare workers or other high risk professionals. but then in the we early of this morning's hours the cdc director said i'm going to break with my advisory committee and i'm going to recommend it in healthcare workers and other at risk. so bottom line, it seems like at this point those 65 and older are going to be eligible for boosters. really anyone that has a pre-existing medical condition and anyone who is considered in high risk professions. bottom line, brian, if you want a booster you are going to be able to go get one. and whether the science supports it or not, who knows. but that's what they're doing. brian: it's just so unbelievable. people on the fence, this makes them throw their hands up in the air and said i told you. they don't even have their act together. they are trumping each other. why should i be in the middle of thi

if they go for an eua, it'll likely be the beginning of november./november timeframe. those who are younger than that will be a little further down. because when you do a study, you do an age de-escalation study. start with 11 to 9, 9 to 6, 6 to 2, and 6 months to 2 years. >> dr. fauci, i'm sure you've answered this before. forgive me for repeating the question. do you have a percentage in mind of americans that need to be vaccinated before we reach a point to really suppress this virus and actually be on the winning side of things? is it 80%? is it 85%? is it 90% of americans? >> joe, we don't know. you know, any time you give a number, someone will poke holes in it. what i think is as close to the truth as you will get, you'll know it when you see it. we should get, we, us here in the united states, should get as many people vaccinated as we possibly can. when we get to the point where it is that critical number that we are not sure of what it is, you're going to see the level of infections plummet very, very low, and maybe even disappear. take, f

hr 3705 that would allow vaccine sponsors who have received an eua to communicate information about the vaccines with certain entities without fear of violating a law. based on what you said, i think you think something along those lines would be helpful for producers of the vaccines, the developers, but also for the health care providers and those of us who rely on our health care providers to give us information. am i reading that correctly? >> yes. >> i appreciate that. thank you for your testimony. i'm going to switch over to dr. maldonado. in talking with mr. butterfield, you mentioned tuberculosis. i have been looking at therapy and i do not know -- that is a bacterial infection. do we have a vaccine? is there a vaccine in the works for tuberculosis? >> we have been working on a vaccine for tuberculosis for 30 plus years. there has been recent updates. there has been a vaccine in the past five years that seem to do a reasonable job. it is about 30% effective. we really have not advanced as well. tuberculosis is very complicated. it is a bacterial infection. we do not understand ve